MABT356 Sigma-AldrichAnti-Integrin alpha6 Antibody, clone 6H7.1
This Anti-Integrin alpha6 Antibody, clone 6H7.1 is validated for use in Western Blotting and Immunohistochemistry (Paraffin) for the detection of Integrin alpha6.
More>> This Anti-Integrin alpha6 Antibody, clone 6H7.1 is validated for use in Western Blotting and Immunohistochemistry (Paraffin) for the detection of Integrin alpha6. Less<<Anti-Integrin alpha6 Antibody, clone 6H7.1 MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | WB, IH(P) | M | Purified | Monoclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| MABT356 | 04055977277036 |
Documentation
Anti-Integrin alpha6 Antibody, clone 6H7.1 MSDS
| 职位 |
|---|
Anti-Integrin alpha6 Antibody, clone 6H7.1 分析证书
| 标题 | 批号 |
|---|---|
| Anti-Integrin alpha6, clone 6H7.1 - 3330363 | 3330363 |
| Anti-Integrin alpha6, clone 6H7.1 - 4069737 | 4069737 |
| Anti-Integrin alpha6, clone 6H7.1 -Q2595862 | Q2595862 |
技术信息
| 标题 |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



